Validity of different linguistic versions of the Alzheimer's disease Assessment Scale in an international multicentre Alzheimer's disease trial

被引:13
作者
Inzitari, D
Rossi, R
Lamassa, M
Mugnai, S
Carlucci, G
Bianchi, C
Amaducci, L
机构
[1] Univ Florence, Dept Neurol & Psychiat Sci, I-50134 Florence, Italy
[2] Bayer Italia SpA, Dept Res & Dev, Milan, Italy
关键词
ADAS; Alzheimer's disease; dementia; validation;
D O I
10.1159/000017131
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Owing to the involvement of Italian Centres in a multicentre, German-Italian therapeutical trial with Alzheimer's dementia patients, to be assessed with the Alzheimer's Disease Assessment Scale (ADAS), it was decided that the Italian centres would use an Italian version of the scale, derived from that used by the German centres. However, the lists of words for exploring verbal memory are not merely translated from the German version, but are composed of selective Italian words chosen according to linguistic criteria, This Italian version was validated following the same procedure adopted for validating the German version, We submitted this Italian version to an interrater reliability, test-retest reliability, concurrent validity, internal consistency and sensitivity evaluation, using demented patients, Based on the results of these tests this Italian version of the ADAS proved valid and reliable. Moreover, the results were strikingly comparable to those from the validation of the German version. Our work supports the validity, reliability and transnational comparability of national versions of the ADAS constructed following definite linguistic criteria.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 50 条
[1]  
[Anonymous], 1994, LESSICO FREQUENZA IT
[2]  
BASCHEK J, 1987, Z EXP ANGEW PSYCHOL, V24, P353
[3]   EFFECTS OF METRIFONATE, A LONG-ACTING CHOLINESTERASE INHIBITOR, IN ALZHEIMER-DISEASE - REPORT OF AN OPEN TRIAL [J].
BECKER, RE ;
COLLIVER, J ;
ELBLE, R ;
FELDMAN, E ;
GIACOBINI, E ;
KUMAR, V ;
MARKWELL, S ;
MORIEARTY, P ;
PARKS, R ;
SHILLCUTT, SD ;
UNNI, L ;
VICARI, S ;
WOMACK, C ;
ZEC, RF .
DRUG DEVELOPMENT RESEARCH, 1990, 19 (04) :425-434
[4]   Behavioral disorders in Alzheimer disease: A transcultural perspective [J].
Binetti, G ;
Mega, MS ;
Magni, E ;
Padovani, A ;
Rozzini, L ;
Bianchetti, A ;
Trabucchi, M ;
Cummings, JL .
ARCHIVES OF NEUROLOGY, 1998, 55 (04) :539-544
[5]   PENTOXIFYLLINE IN CEREBROVASCULAR DEMENTIA [J].
BLACK, RS ;
BARCLAY, LL ;
NOLAN, KA ;
THALER, HT ;
HARDIMAN, ST ;
BLASS, JP .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1992, 40 (03) :237-244
[6]   Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease [J].
Bodick, NC ;
Offen, WW ;
Levey, AI ;
Cutler, NR ;
Gauthier, SG ;
Satlin, A ;
Shannon, HE ;
Tollefson, GD ;
Rasmussen, K ;
Bymaster, FP ;
Hurley, DJ ;
Potter, WZ ;
Paul, SM .
ARCHIVES OF NEUROLOGY, 1997, 54 (04) :465-473
[7]  
BURCH EA, 1987, INT J PSYCHIAT MED, V17, P193
[8]   4-AMINOPYRIDINE IN THE TREATMENT OF ALZHEIMERS-DISEASE [J].
DAVIDSON, M ;
ZEMISHLANY, Z ;
MOHS, RC ;
HORVATH, TB ;
POWCHIK, P ;
BLASS, JP ;
DAVIS, KL .
BIOLOGICAL PSYCHIATRY, 1988, 23 (05) :485-490
[9]  
De Mauro T., 1980, Guida all'uso delle parole
[10]   MILACEMIDE - A PLACEBO-CONTROLLED STUDY IN SENILE DEMENTIA OF THE ALZHEIMER TYPE [J].
DYSKEN, MW ;
MENDELS, J ;
LEWITT, P ;
REISBERG, B ;
POMARA, N ;
WOOD, J ;
SKARE, S ;
FAKOUHI, JD ;
HERTING, RL .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1992, 40 (05) :503-506